Cucurbitacin D isolated from Trichosanthes kirilowii induces apoptosis in human hepatocellular carcinoma cells in vitro

International Immunopharmacology

Volumn 9, Issue 4, 2009, Pages 508-513

  Takahashi, Norito ^a   Yoshida, Yasuhiro ^a   Sugiura, Tsutomu ^a   Matsuno, Koji ^b   Fujino, Akihiro ^a   Yamashita, Uki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KYUSHU UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Apoptosis; Caspase 3; Cucurbitacin D; Hepatocellular carcinoma; JNK; Trichosanthes kirilowii

Indexed keywords

CASPASE 3; CUCURBITACIN GLYCOSIDE; CYTOCHROME C; DIHYDROCUCURBITACIN D; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; DOSE RESPONSE; DRUG ISOLATION; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FAST ATOM BOMBARDMENT MASS SPECTROMETRY; FLOW CYTOMETRY; HEP3B CELL; HERB; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; NICK END LABELING; PRIORITY JOURNAL; TRICHOSANTHES KIRILOWII; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; LIVER NEOPLASMS; MAP KINASE KINASE 4; MEDICINE, TRADITIONAL; PLANT ROOTS; TRICHOSANTHES; TRITERPENES;

EID: 61649114173     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.01.006     Document Type: Article

References (22)

1. P.B. Fontanarose (ed.), Alternative Medicine, JAMA, AMA, Chicago: 2000.
2. Ernst E. The risk-benefit profile of commonly used herbal therapies: Gingo, St. John's Wort, ginseng, echinacea, saw palmetto, and kava. Ann Intern Med 136 (2002) 42-53
3. Yamada H., and Nagai T. In vivo antiinfluenza virus activity of Kampo medicine Sho-seiryu-to through mucosal immune system. Methods Find Exp Clin Pharmacol 20 (1998) 185-192
4. Japanese Oriental Medicine Association(ed.). Introducing Kampo Medicine, Nankodo,Tokyo: 2002 (in Japanese).
5. Lu P.X., and Jim Y.V. Trichosanthin in the treatment of hydatidiform mole. Clinical analysis of 52 cases. Clin Med J 103 (1990) 183-185
6. Chan S.H., Hung F.S., Chan D.S., and Shaw P.C. Trichosanthin interacts with acidic ribosomal proteins P0 and P1 and mitotic checkpoint protein MAD2B. Eur J Biochem 268 (2001) 2107-2112
7. Wang P., and Li J.C. Trichosanthin-induced specific changes of cytoskeleton configuration were associated with the decreased expression level of actin and tubulin genes in apoptotic Hela cells. Life Sci 31 (2007) 1130-1140
8. Dou C.M., and Li J.C. Effect of extracts of trichosanthes root tubers on HepA-H cells and HeLa cells. World J Gastroenterol 10 (2004) 2091-2094
9. Kitajima J., and Tanaka Y. Studies on the constituents of trichosanthes root. I. Constituents of roots of Trichosanthes kirilowii Maxim. var. japonicum Kitam. Yakugaku Zasshi 109 (1989) 250-255 (in Japanese)
10. 4 of an allylethercholine-phospholipid, archaetidylcholine, from the hyperthermophilic methanarchaeon Methanopyrus kandleri. Archaea 1 (2002) 123-131
11. 2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway. J Pharmacol Exp Ther 307 (2003) 505-517
12. Gekle M., Schwerdt G., Freudinger R., Mildenberger S., Wilflingseder C., Pollack V., et al. Ochratoxin A induces JNK activation and apoptosis in MDCK-C7 cells at nanomolar concentrations. J Pharmacol Exp Ther 293 (2000) 837-844
13. Salvesen G.S., and Dixit V.M. Caspase activation: the induced-proximity model. Proc Natl Acad Sci U S A 96 (1999) 10964-10967
14. Blaskovich M.A., Sun J., Cantor A., Turkson J., and Sebti S.M. Discovery of JSI-124(cucurbitacin I), a selective Janus kinases/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res 63 (2003) 1270-1279
15. Shi X., Franko B., Frantz C., Amin H.M., and Lai R. JSI-124 (cucurbitacin I) inhibits Janus kinase-3/signal transducer and activator of transcription-3 signaling, down regulates nucleophosmin-anaplastic lymphoma kinase(ALK), and induces apoptosis in ALK-positive anaplastic large cell lymphoma cells. Brit J Haematol 135 (2006) 26-32
16. Sun J., Blaskovich M.A., Jove R., Livingston S.K., Coppola D., and Sebti S.M. Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity. Oncogene 24 (2005) 3236-3245
17. Duncan K.L., Duncan M.D., Alley M.C., and Sausville E.A. Cucurbitacin E-induced disruption of the actin and vimentin cytoskeleton in prostate carcinoma cells. Biochem Pharmacol 52 (1996) 1553-1560
18. Yin D., Wakimoto N., Xing H., Liu D., Huynh T., Wang X., et al. Cucurbitacin B markedly inhibits growth and rapidly affects the cytoskeketon in glioblastoma multiforme. Intern J Cancer 123 (2008) 1364-1375
19. Duncan M.D., and Duncan K.L. Cucurbitacin E targets proliferating endothelia. J Surg Res 69 (1997) 55-60
20. Blum H.E. Hepatocellular carcinoma: therapy and prevention. World J Gastroenterol 11 (2005) 7391-7400
21. Wilson J.F. Liver cancer on the rise. Ann Intern Med 142 12 Pt1 (2005) 1029-1032
22. Johnson P.J. Hepatocellular carcinoma: is current therapy really altering outcome?. Gut 51 (2002) 459-462